Literature DB >> 10382170

Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.

N M Hylton1.   

Abstract

Gadolinium-enhanced MR imaging techniques can be used to assess both breast tumor morphology and vascularity. Pharmacokinetic models can be used to extract physiological parameters related to tumor vascularity from signal intensity-time curves. This article describes an empirical method, using three-point high resolution MR imaging, that also provides assessment of tumor vascularity. These techniques appear to improve diagnostic specificity of breast MR imaging and provide a noninvasive method for tumor characterization that may have prognostic value.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382170

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  24 in total

1.  Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

Authors:  Nola M Hylton; Jeffrey D Blume; Wanda K Bernreuter; Etta D Pisano; Mark A Rosen; Elizabeth A Morris; Paul T Weatherall; Constance D Lehman; Gillian M Newstead; Sandra Polin; Helga S Marques; Laura J Esserman; Mitchell D Schnall
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

2.  Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.

Authors:  Wen Li; David C Newitt; Lisa J Wilmes; Ella F Jones; Vignesh Arasu; Jessica Gibbs; Bo La Yun; Elizabeth Li; Savannah C Partridge; John Kornak; Laura J Esserman; Nola M Hylton
Journal:  J Magn Reson Imaging       Date:  2019-04-26       Impact factor: 4.813

3.  Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.

Authors:  Nola M Hylton; Constantine A Gatsonis; Mark A Rosen; Constance D Lehman; David C Newitt; Savannah C Partridge; Wanda K Bernreuter; Etta D Pisano; Elizabeth A Morris; Paul T Weatherall; Sandra M Polin; Gillian M Newstead; Helga S Marques; Laura J Esserman; Mitchell D Schnall
Journal:  Radiology       Date:  2015-12-01       Impact factor: 11.105

4.  High resolution in vivo characterization of apparent diffusion coefficient at the tumor-stromal boundary of breast carcinomas: a pilot study to assess treatment response using proximity-dependent diffusion-weighted imaging.

Authors:  Rebekah L McLaughlin; David C Newitt; Lisa J Wilmes; Ella F Jones; Dorota J Wisner; John Kornak; Evelyn Proctor; Bonnie N Joe; Nola M Hylton
Journal:  J Magn Reson Imaging       Date:  2013-10-08       Impact factor: 4.813

5.  Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions?

Authors:  Vignesh A Arasu; Ryan C-Y Chen; David N Newitt; C Belinda Chang; Hilda Tso; Nola M Hylton; Bonnie N Joe
Journal:  Acad Radiol       Date:  2011-03-21       Impact factor: 3.173

6.  Real-Time Measurement of Functional Tumor Volume by MRI to Assess Treatment Response in Breast Cancer Neoadjuvant Clinical Trials: Validation of the Aegis SER Software Platform.

Authors:  David C Newitt; Sheye O Aliu; Neil Witcomb; Gal Sela; John Kornak; Laura Esserman; Nola M Hylton
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

7.  Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging.

Authors:  Marjan S Bolouri; Sjoerd G Elias; Dorota J Wisner; Spencer C Behr; Randall A Hawkins; Sachiko A Suzuki; Krysta S Banfield; Bonnie N Joe; Nola M Hylton
Journal:  Radiology       Date:  2013-07-22       Impact factor: 11.105

8.  Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.

Authors:  Peter R Eby; Savannah C Partridge; Steven W White; Robert K Doot; Lisa K Dunnwald; Erin K Schubert; Brenda F Kurland; Constance D Lehman; David A Mankoff
Journal:  Acad Radiol       Date:  2008-10       Impact factor: 3.173

9.  Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging.

Authors:  Ka-Loh Li; Roland G Henry; Lisa J Wilmes; Jessica Gibbs; Xiaoping Zhu; Ying Lu; Nola M Hylton
Journal:  Magn Reson Med       Date:  2007-09       Impact factor: 4.668

10.  DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.

Authors:  Xia Li; Lori R Arlinghaus; Gregory D Ayers; A Bapsi Chakravarthy; Richard G Abramson; Vandana G Abramson; Nkiruka Atuegwu; Jaime Farley; Ingrid A Mayer; Mark C Kelley; Ingrid M Meszoely; Julie Means-Powell; Ana M Grau; Melinda Sanders; Sandeep R Bhave; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2013-05-09       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.